-

Taro to Announce Third Quarter Results on February 3, 2020

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2019, after the close of market on Monday, February 3, 2020.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Contacts

William J. Coote
AVP, Treasurer and Investor Relations – Interim CFO
(914) 345-9001
William.Coote@Taro.com

Industry:

Taro Pharmaceutical Industries Ltd.

NYSE:TARO
Release Summary
TARO TO ANNOUNCE THIRD QUARTER RESULTS ON FEBRUARY 3, 2020
Release Versions
English

Contacts

William J. Coote
AVP, Treasurer and Investor Relations – Interim CFO
(914) 345-9001
William.Coote@Taro.com

More News From Taro Pharmaceutical Industries Ltd.

Taro Provides Results for Year Ended March 31, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024...

Taro to Release Full Year Results on May 20, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO TO RELEASE FULL YEAR RESULTS ON MAY 20, 2024...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger

NEW YORK--(BUSINESS WIRE)--Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger...
Back to Newsroom